Medicine News
Diabetes drug pioglitazone may up bladder cancer risk
Pioglitazone - a drug used to treat type 2 diabetes - appears to increase risk of developing bladder cancer, a new study has warned.
The results show that more than two years daily exposure to pioglitazone doubles the risk of bladder cancer.
But the researchers noted that in absolute terms, the risks are low - up to 137 extra cases per 100,000 person years.
No increased risk was seen for a similar
Medicine Galleries
Medicine Videos
|
|
